The announcement of a public offering often leads to a decrease in stock price due to the dilution of existing shares. In this case, Helius Medical Technologies' decision to price a $6.4 million offering, including a significant number of Class A common shares and pre-funded warrants, has led to a negative short-term impact on its stock price. This is a common market reaction as investors adjust to the increased supply of shares and potential dilution of value.